Edition:
United Kingdom

Erytech Pharma SA (ERYP.PA)

ERYP.PA on Paris Stock Exchange

6.61EUR
24 May 2019
Change (% chg)

€0.00 (+0.00%)
Prev Close
€6.61
Open
€6.69
Day's High
€6.71
Day's Low
€6.57
Volume
13,480
Avg. Vol
36,027
52-wk High
€16.89
52-wk Low
€5.61

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.00 -0.650
FY 2018 Dec '18 2.18 -1.071
Jun '18 2.27 -1.060
FY 2017 Dec '17 1.58 -1.516
Jun '17 1.79 -1.420
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-19 3 8.23 13.00 4.00 11.65
Year Ending Dec-20 3 15.87 35.00 3.00 36.50
Earnings (per share)
Year Ending Dec-19 3 -3.16 -2.73 -3.54 -2.50
Year Ending Dec-20 3 -2.79 -2.36 -3.10 -1.27
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 93.20 35.48
P/E High - Last 5 Yrs. -- 165.14 57.43
P/E Low - Last 5 Yrs. -- 51.92 28.10
Beta 1.38 1.21 0.95
Price to Sales (TTM) -- 40.13 9.28
Price to Book (MRQ) -- 11.48 4.15
Price to Tangible Book (MRQ) -- 16.72 4.94
Price to Cash Flow (TTM) -- 61.14 24.38
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.11 1.68
Dividend Yield - 5 Year Avg 0.00 0.06 1.30
Dividend 5 Year Growth Rate -- 0.94 6.71
Payout Ratio(TTM) -- 1.56 35.42

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 59.08 16.40
Sales (TTM) vs TTM 1 Yr. Ago -- 46.19 8.26
Sales - 5 Yr. Growth Rate 19.80 32.98 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -- -9.33 19.71
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 22.17 7.23
Capital Spending - 5 Yr. Growth Rate 102.43 24.87 8.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.77 2.43
Current Ratio (MRQ) -- 3.84 3.36
LT Debt to Equity (MRQ) -- 7.71 14.37
Total Debt to Equity (MRQ) -- 20.81 19.78
Interest Coverage (TTM) -- 32.37 13.53

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 22.42 50.23
Gross Margin - 5 Yr. Avg. -- 59.23 51.31
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -704.16 -16.11 15.84
Operating Margin (TTM) -- -116.39 -4.60
Operating Margin - 5 Yr. Avg. -718.37 -31.95 11.09
Pre-Tax Margin (TTM) -- -116.40 -4.95
Pre-Tax Margin - 5 Yr. Avg. -695.43 -34.49 15.89
Net Profit Margin (TTM) -- -121.99 -8.72
Net Profit Margin - 5 Yr. Avg. -695.35 -39.40 11.14
Effective Tax Rate (TTM) -- 17.16 19.94
Effective Tax Rate - 5 Yr. Avg. -- 18.91 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 8,861,170 746,541,307
Net Income/Employee (TTM) -- 1,554,572 87,192,468
Receivable Turnover (TTM) -- 11.38 5.67
Inventory Turnover (TTM) -- 2.45 3.66
Asset Turnover (TTM) -- 0.33 0.79

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 6.13 9.44
Return on Assets - 5 Yr. Avg. -27.54 6.07 10.47
Return on Investment (TTM) -- 7.47 11.75
Return on Investment - 5 Yr. Avg. -30.39 7.95 13.33
Return on Equity (TTM) -- 7.94 16.52
Return on Equity - 5 Yr. Avg. -30.96 9.00 14.90
  1 Year 3 Year 5 Year
Sales % 32.19 14.93 19.80
EPS (TTM) % 27.74 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Erytech Pharma SA

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -8.32 -3.96 85 7
13 Week -9.58 -11.29 83 16
26 Week 2.56 -4.57 99 7
52 Week -60.25 -58.52 46 12
YTD 5.76 -5.89 96 4
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 47.55%
# of Holders: 20
Total Shares Held: 8,529,748
3 Mo. Net Change: 14,712
# New Positions: 2
# Closed Positions: 0
# Increased Positions: 4
# Reduced Positions: 1
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.